Summary.-Peritoneal macrophages from Sarcoma-180-bearing mice against Staphylococcus aureus were studied to determine the in vitro phagocytic capacities. When the phagocytic system was opsonized with normal mouse serum, macrophage phagocytic activity increased markedly soon after tumour graft and then returned to normal. A new antiphagocytic factor was detected in the serum of tumour-bearers soon after tumour implantation. This factor was of tumour origin, stable even at a temperature of 56°C for 30 min and non -dialysable. Peptone-starch-induced macrophages were less sensitive to the factor than their unstimulated counterpart.
CONFLICTING observations have been reported on the state of macrophage phagocytic function in tumour-bearers. The carbon-clearance ability of the reticuloendothelial system, the nonspecific phagocytic function performed mainly by liver macrophages, is severely repressed soon after Lewis lung carcinoma transplantation in mice (Otu et al., 1977) . It was reported by Gudewicz & Saba (1977) that alveolar macrophages from Walker 256 carcinosarcoma-bearing rats showed considerably depressed phagocytic activity against Pseudomonas aeruginosa. There is other evidence, however, that neoplastic disease induces a stimulation of macrophage phagocytic function. For instance, Meltzer & Stevenson (1978) reported that phagocytosis of IgG-coated sheep erythrocytes by macrophages was significantly augmented in tumour-bearing mice.
The present study was undertaken to determine whether or not the alteration of phagocytic capacity can be detected in macrophages from Sarcoma-180-bearing animals, using viable Staphylococcus aureus as the phagocytic material. We also attempted to examine whether or not changes in capacity of macrophage phagocytosis are caused by a factor of tumour origin.
We found that phagocytosis of bacteria by macrophages from tumour-bearers was remarkably enhanced in the early phase after tumour implantation. We also found a suppressive factor against macrophage phagocytic function with a mol. wt > 10,000 in the mouse serum soon after tumour graft.
MATERIALS AND METHODS
Mice.-Colony-bred DD mice of both sexes were purchased from Shizuoka Union for Experimental Animals, Shizuoka, Japan.
Tumour.-Sarcoma-180 (S-180) an allotransplantable tumour kindly provided by Dr I. Umezawa (Kitasato Institute, Tokyo) was maintained by serial s.c. passage in DDY mice. The tumour was excised under aseptic conditions and finely minced in phosphatebuffered saline (PBS, pH 7.2) containing 100 jug/ml of streptomycin. The resulting cell suspension was filtered through an 80-mesh stainless-steel screen and wa,shed once with PBS. Usually each animal was given 106 tumour cells s.c. into the right flank.
Bacterium.-S. aureus Strain 209P was obtained from Dr Y. Kanemasa (Okayama University, Medical School, Okayama., Japan) and maintained in heart-infusion agar. The organism was inoculated into brain/heart infusion broth (Difco Lab., U.S.A.) and cultured at 37T for [18] [19] [20] [21] [22] [23] [24] Cohn & Morse (1959) . The phagocytosing mixture (0 5 ml) in siliconized sterile tubes (10 x 100 mm) contained 1-4-38 X 106 PC or PEC, 105 bacteria, sample serum, and HBG. The tubes were sealed with rubber stoppers and then incubated at 37°C on a reciprocal shaker at 160-180 cycles/min. At intervals of up to 240 min, phagocytosis was stopped by the addition of 5 ml of cold PBS containing 0.05% bovine serum albumin, followed by centrifugation at 200 g for 4 min.
In a preliminary test, no significant reduction in the recovery of extracellular bacteria was noted after this centrifugation procedure. From the upper one third of the tube, 0.5 ml of the supernatant was withdrawn and counted for its CFU on nutrient agar plates.
For the microscopic assay, phagocytosis was performed in the same manner as described above except for the incubation mixture: 1 2 x 106 PC or PEC, 8 x 105 bacteria, sample serum, and HBG. After phagocytosis, the cell pellet obtained by centrifugation at 200 g for 4 min was smeared, fixed with methanol, and stained with Giemsa solution. By light microscopy, the number of macrophage-ingested bacteria was counted, and the percentage of the phagocytosing cells to total macrophages was calculated (% phagocytosing cells). In some cases, the mean number of ingested bacteria per phagocyte was also recorded.
S-180 tumour-cell culture.-S-180 tumourcell suspension prepared by the method mentioned above ("Tumour") from tumour-bearers was not altered significantly for up to 20 days after tumour implantation. In contrast, phagocytosis in the presence of NMS markedly increased on the 1st day, persisted through the 5th day, and returned to almost normal levels by the 20th day (the increases 1-5 days after tumour graft were statistically significant, P < 0-005 by x2 test). On the other hand, phagocytosis in the presence of serum from tumour bearers (S-180 MS) remarkably increased on the 1st day (P < 0'005 by x2 test), rapidly decreased by the 3rd day, remained low for 2 additional days, and then gradually returned to the 1st-day level.
These findings indicate that the phagocytic activity of macrophages against S. aureus is enhanced, particularly in the latent period of the tumour growth. It is also suggested that the opsonic activity of S-180 MS is reduced 3-5 days after tumour transplantation.
Decrease in opsonic activity of S-180 MS after tumour graft
To ascertain the net changes in opsonizing ability of S-180 MS after tumour injection, the value of the "relative 
Antiphagocytic factor in S-180 MS
The results shown in Fig. 2 suggest the presence of an antiphagocytic substance, since decreased opsonic activity of S-180 MS was not fully overcome by supplemental addition of NMS as the opsonin source. We therefore attempted to determine whether a similar phenomenon could be also observed using macrophages from normal mice by microscopic assay. As shown in Fig. 3 supplemented with a sufficient amount of serum opsonins, by further addition of NMS. On the contrary, as shown also in Fig. 3 , bacterial phagocytosis of polymorphonuclear leucocytes (PMN; shaded bar) was not reduced as significantly as in the case of macrophages, when S-180 MS was added instead of NMS. It is noteworthy that stimulation of PMN phagocytosis by the addition of NMS as the opsonin source was not as marked as in the case of macrophages. These observations indicate that S-180 MS contains an antiphagocytic factor or factors specifically effective on macrophages, but not on PMN.
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As illustrated in Fig. 4 , the phagocytic ability of PEC from normal mice given peptone-starch 3 days before harvest (measured by CFU assay) was also markedly reduced when S-180 MS was added instead of NMS (open triangles vs open circles). In this case, PEC were composed of 70%/ macrophages, 14% PMN, and 16% lymphocytes. Therefore, using the data presented in Fig. 3 , it may be estimated that about 8.3% of the total bacterial phagocytosis of the PEC in the presence of 10% NMS is due to contaminating PMN. Similarly, when 10% S-180 MS was added instead of NMS, the contaminating PMN can be regarded as the cause of about 16% of the total phagocytosis. However, since the present antiphagocytic factor specifically acts on macrophages but not on PMN as indicated in Fig. 3 , the reduction of bacterial phagocytosis observed here can be regarded as mainly due to the depression of the phagocytic capacity of macrophages, but not of PMN. Furthermore, there was no reversal of the reduction of macrophage phagocytosis when S-180 MS was supplemented with a further addition of NMS as the opsonin source (solid triangles). This indirectly suggests that the reduced macrophage phagocytic capacity in the presence of S-180 MS is not corrected by supplemental addition of NMS, because the bacterial phagocytic activity of PMN did not differ significantly between the cases where S-180 MS was added alone or with supplemental NMS, as shown in Fig. 3 . These observations indicate again that S-180 MS has a suppressive factor against macrophage phagocytic function.
It was also noted that S-180 MS exhibited a dose-dependent suppression of the bacterial phagocytosis of macrophages (data not shown).
Stimulated macrophages have a reduced sensitivity to the antiphagocytic factor As can be seen in the first column of Table I (Experiment 1) percentage reductions in "relative opsonization index" (which means the sensitivity of macrophages to the action of the present antiphagocytic factor) were 63 + 20 and 29 + 400 for resident and peptone-starchstimulated macrophages, respectively. In this case, bacterial phagocytosis tests were performed on PC and PEC from normal mice by the CFU assay. The PC and PEC used here were found to be composed of 70 and 65% mononuclear phagocytes, and to be contaminated with 7*3 and 10% PMN respectively. Therefore it seems that bacterial phagocytosis due to contaminating PMN dose not exceed 10% of total phagocytosis in both cases, at most, since PMN phagocytic capacity was found to be less than (or equal to) that of macrophages in the presence of various serum supplements as shown in Fig. 3 . Moreover, as can be seen in Fig. 3 Table II . When 10% of S-180 MS was added to the phagocytozing incubation mixture (using peptone-starch-induced PEC from normal mice as phagocytes) with a supplementary addition of an equal amount of NMS, the extracellular CFU after 2h phagocytosis was nearly twice that of the control (20% NMS added) indicating the antiphagocytic action of S-180 MS. A similar degree of antiphagocytic activity was also noted when 10% S-180 MS which had been thoroughly dialysed against PBS, in place of untreated S-180 MS, was added to the phagocytosis system. Thus, it appears that the antiphagocytic factor does not pass through the dialysis membrane. It was also found that addition of 10% of heated S-180 MS (560C for 30 min) produced a remarkable reduction in phagocytosis, whereas only a slight decrease was obtained when 100% of NMS similarly treated was added. This indicates that the antiphagocytic factor is stable to heat treatment at 56°C for 30 min. This factor could be precipitated at 50% saturation of ammonium sulphate.
Origin of the antiphagocytic factor
In attempts to determine the origin of this antiphagocytic factor, we investigated whether or not a similar factor is produced by S-180 tumour cells in vitro. Three-day cultured fluid of S-180 tumour cells was dialysed against PBS and fractionated with 50%-saturated ammonium sulphate.
The precipitate was redissolved in PBS, dialysed against the same buffer, and then made up to 1/15 volume of starting culture fluid. This was sterilized for 5 min by UVirradiation using a 15W UV lamp at 20 cm.
As indicated in Fig. 5 , phagocytic ability of peptone-starch-induced macrophages from normal mice linearly decreased as the amount of fraction obtained from S-180 cell culture fluid increased. Thus, the antiphagocytic factor is apparently produced in the culture fluid of (Meltzer & Stevenson, 1978) .
The serum from tumour-bearing mice showed a remarkable reduction in opsonizing activity soon after tumour graft. This situation can be mainly attributed to the presence of some antiphagocytic factor of tumour origin in S-180 MS, since the supplementary addition of NMS (as an opsonin source) into the phagocytic system failed to reverse the depression of opsonic activity in S-180 MS. However, it is not clear whether this antiphagocytic factor merely acts as a competitive inhibitor against serum opsonins or actually alters the macrophage phagocytic function.
The present antiphagocytic factor was stable to heat treatment at 56°C for 30 min and non-dialysable through dialysis nmembrane. Thus, it probably has a mol. wt > 10,000. In addition, it was observed that cultured S-180 tumour cells actually produced a similar antiphagocytic factor. Accordingly, the antiphagocytic factor detected in S-180 MS is considered to originate from S-180 tumour cells per se.
The present antiphagocytic factor of S-180 tumour origin seems to differ from
the humoral factor of Hepatoma 129 origin which has an inhibitory activity on macrophage chemotaxis (Pike & Snyderman, 1976) or the factor of SAI spindle-cell sarcoma origin with a suppressive activity against macrophage bactericidal function (North et al., 1976a) . Both these factors are dialysable and their mol. wts are considered to be < 10,000. It is noteworthy that the antiphagocytic factor of S-180 tumour origin showed no significant inhibitory action against macrophage staphylocidal activity (data not shown).
The depressed state of opsonizing ability of S-180 MS 3-5 days after tumour graft was subsequently restored, and replaced by a contrasting state, somewhat more active than NMS. As indicated by North et al. (1976b North et al. ( , 1977 it seems likely that this phenomenon coincided with the expression of T-cell-mediated concomitant immunity to tumour in the recipient mice, i.e. the appearance of T-cell-derived stimulating factor(s) of macrophage phagocytosis in the serum of S-180 tumour-bearers after the latent period of tumour growth.
As indicated in Table I , peptone-starchinduced macrophages were more resistant to the antiphagocytic action of the present S-180 tumour factor than the resident macrophages. This suggests that stimulation of macrophages with certain agents can overcome the subversion of the phagocytic function by the tumour factor.
Our results may assist in elucidating the conflicting data of Meltzer & Stevenson (1978) and Otu et al. (1977) concerning the macrophage phagocytic function in tumour-bearers. The former found in in vitro studies that macrophage phagocytosis of IgG-coated erythrocytes was markedly increased in cases of Fibrosarcoma 1038-and Hepatoma 129-bearing mice. It was also reported that the tumour serum failed to suppress the macrophage phagocytic function when the serum was given to normal recipients. On the contrary, Otu et al. (1977) reported that host carbon clearance ability, a nonspecific phagocytic activity of mainly liver macrophages, was considerably reduced early after Lewis lung carcinoma implantation in mice. They also found that the serum from tumour-bearers caused a significant decrease in carbon clearance ability of the recipient mice. In 5-180 tumour-bearing mice, the phagocytic capacity of macrophages from tumour-bearers was enhanced significantly in the latent period of tumour growth, when the in vitro phagocytosis was performed in the presence of a sufficient amount of NMS as the opsonin source. In addition, a large amount of antiphagocytic factor was produced in the serum of tumour-bearing mice also in the latent period of tumour growth. These observations strongly suggest that the stimulation of macrophage phagocytic function soon after tumour graft actually occurs in all the cases, whereas the amount of antiphagocytic factor of tumour origin differs considerably between types of tumours. In the cases of Fibrosarcoma 1038 and Hepatoma 129 (Meltzer & Stevenson, 1978 ) the failure of the tumour sera to depress the macrophage phagocytic ability of the recipient animals indicates a small amount of antiphagocytic factor. In contrast, it appears that a large amount of antiphagocytic factor is produced in the serum of Lewis lung carcinoma-bearing mice as this tumour serum given to normal mice caused a marked reduction in the carbon-clearance ability of liver macrophages of the recipients (Otu et al., 1977) . Therefore the apparent reduction in the carbon-clearance ability of Lewis lung carcinoma-bearers seems to be due to the antiphagocytic effect of the serum factor of tumour origin rather than to a decrease in the macrophage phagocytic function per se.
In any case, the apparent alteration in macrophage phagocytic capacity after tumour transplantation probably depends on the amount (activity) of antiphagocytic factor in the serum of tumour-bearing animals. However, there remains the possibility that the contradictory situations mentioned above are merely due to the different phagocytic particles used in the above studies.
Purification of the antiphagocytic factor of S-180 tumour origin is now under way, and results will be reported elsewhere.
